Thank you for attending the 2017 International Interchange in Austin, Texas. You will find presentations from the conference below.
SESSION 1: OPENING PLENARY & KEYNOTE ADDRESS
OPENING REMARKS
David R. Bobbitt, CDISC President and CEO
OPENING REMARKS
Dr. David Hardison, CDISC Board Chair
KEYNOTE PRESENTATION: IMPACT OF COLLABORATING VS COMPETING TO ACHIEVE SUCCESS IN CLINICAL RESEARCH
Paula Brown Stafford and Lisa T. Grimes, Managing Directors, Habergeon LLC
CDISC: WHAT’S NEW & WHAT’S NEXT
Shannon Labout, CDISC Interim Chief Standards Officer
UPDATE FROM GLOBAL CDISC COORDINATING COMMITTEES (3Cs)
E3C Update - Peter Van Reusel, E3C
AP3C Update - Dr. Zibao Zhang, AP3C
J3C Update - Yoshiteru Chiba, J3C
C3C Update - John Wang, C3C
SESSION 2: SECOND OPENING PLENARY - REGULATORY PRESENTATIONS
FDA-CDER PRESENTATION
Dr. Ron Fitzmartin, FDA-CDER
JAPAN PMDA PRESENTATION
Dr. Mayumi Shikano, PMDA
REAL-WORLD REGULATORY INTERACTION WITH FDA & PMDA ENDORSED CDISC STANDARDS
Mark Penniston & Terek Peterson, Chiltern
REDACTION OF PROTECTED HEALTH INFORMATION WHILE SUBMITTING SDTM OR ADaM DATASETS TO FDA: A CLINICAL PROGRAMMER’S PERSPECTIVE
Venu Perla, Emmes
PREPARING ADaM DATA SETS AND RELATED FILES FOR FDA SUBMISSION
Sandra Minjoe, Accenture
SESSION 3, TRACK A: TABULATION & ANALYSIS - SEND, SDTM & ADAM
WHY REINVENT THE WHEEL? CAN SDTM PAVE A PATH FOR SEND DATASET CREATION?
Aishwarya Balajee, Zifo
THINKING BEYOND INDIVIDUAL DATASETS: DESIGNING AN EFFICIENT AND TRACEABLE ADAM PACKAGE
Dana Soloff, Mandira Consulting
SDTM TO ADaM: EXAMPLE OF CARDIOVASCULAR PRIMARY ENDPOINT
Yingshan You, Johnson & Johnson
SDTM: IT IS NOT ALL BLACK AND WHITE
Swapna Pothula, SGS Life Sciences
SESSION 3, TRACK B: DATA COLLECTION - PROTOCOL, CDASH & CONTROLLED TERMINOLOGY
THE SCRUM-JAPAN REGISTRY FOR ONCOLOGY AGENT DEVELOPMENT AND CDISC STANDARDIZATION
Yoshihiro Aoyagi, National Cancer Center Hospital East
IMPLEMENTING CDASH AND SDTM FOR CLINICAL TRIALS AND DASHBOARDS
Jaskiran Singh, NIH
TRANSCELERATE’S COMMON PROTOCOL TEMPLATE: MAXIMIZING THE OPPORTUNITY OF DATA STANDARDS
Bill Lander, GlaxoSmithKline
ADVANCING ON THE HOLY GRAIL OF CDISC STANDARDS: THE CASE FOR CDISC-CONTROLLED PROTOCOL SEMANTICS
Melissa Cook, MC Consulting; Erin Muhlbradt, NCI-EVS
SESSION 3, TRACK C: CDISC FOR NEWCOMERS - OVERVIEW OF CDISC IN THE WORLD OF DATA STANDARDS
WHO/WHEN: CDISC HISTORY AND EVOLUTION
Rhonda Facile, CDISC; and Dr. Stephen Wilson, CDISC
WHY: THE PURPOSE AND BENEFIT OF STANDARDS
Dr. Wenjun Bao, JMP Life Sciences; and Peter Van Reusel, Innovion
HOW: COPS, TOOLS AND PROCESSES REVIEW
Dr. Diane Wold, CDISC
SESSION 4, TRACK A: SUBMISSION - SDTM, SEND, ADaM & DEFINE-XML
INCREASE QUALITY AND REDUCE SDTM DEVELOPMENT TIME WITH A MOCK STUDY DATA SIMULATOR
Terek Peterson, Chiltern
SDTM TO ADaM + STANDARD SAFETY REPORTING CODE = EFFICIENT A&R: A MIDDLE-TO-END APPROACH
Valerie Williams, ICON Plc
DATA INTEGRATION OUGHT TO BE AUTOMATED!
Sandy Lei, Johnson & Johnson
BUILDING A COMPLIANT CDISC DATASET THROUGH METADATA PROGRAMMING
Frank Senk, GCE Solutions
SESSION 4, TRACK B: GOVERNANCE - STANDARDS GOVERNANCE, VERSIONING & TRANSLATIONS
STANDARDS VERSION MANAGEMENT: LESSONS LEARNED FROM UPGRADING A COMPANY’S BASE CDISC VERSIONS
Keith Hibbetts, Eli Lilly
CHALLENGES FACING STANDARDS GOVERNANCE AND HOW TO ADDRESS THEM
Diane Piper, Shire
CHALLENGES IN CREATING JAPANESE TRANSLATION OF CDISC ADaM IG
Yumiko Asami, Daiichi Sankyo
BRIDGING THE GAP BETWEEN LEGACY AND CDISC STANDARDS
Bill Qubeck, d-Wise
SESSION 4, TRACK C: CDISC FOR NEWCOMERS - CONNECTED CDISC STANDARDS
CONTROLLED TERMINOLOGY & QUESTIONNAIRES
Erin Muhlbradt, NCI-EVS
OPERATIONAL DATA MODEL (ODM) - XML
Sally Cassells, Next Step Clinical Systems
CDASH AND SDTM: WHY YOU NEED BOTH
Kit Howard, CDISC
ANALYSIS DATA MODEL (ADaM)
Nate Freimark, Greisser Group
SESSION 5, TRACK A: SHARE & METADATA REPOSITORIES
SHARE 2.0
Dr. Lauren Becnel, CDISC
MERCK’S MDR SYSTEM IMPLEMENTATION JOURNEY
Mike Hamidi, Merck
METADATA REPOSITORIES, VERSION CONTROL AND STANDARDS GOVERNANCE LEVERAGING CDISC XML TECHNOLOGY
Philippe Verplancke, XClinical
INFORMATION ARCHITECTURES FOR END-TO-END DATA STANDARDS ADOPTION - A TRANSCELERATE PERSPECTIVE
Frederik Malfait, TransCelerate BioPharma
METADATA REPOSITORY IMPLEMENTATION
Barrie Nelson, NuroCor
SESSION 5, TRACK B: CDISC & PhUSE
OVERVIEW OF THE PhUSE COMPUTATIONAL SCIENCE SYMPOSIUM
Chris Decker, d-Wise
IN-DEPTH REPORT FROM THE NONCLINICAL WORKING GROUP
William Houser, Bristol-Myers Squibb
IN-DEPTH REPORT FROM THE OPTIMIZING DATA STANDARDS WORKING GROUP
Mike Hamidi, Merck; and Todd Bazin, Biogen
SESSION 5, TRACK C: CDISC FOR NEWCOMERS - STANDARDS DEVELOPMENT PROCESS
OVERVIEW OF STANDARDS DEVELOPMENT AND GOVERNANCE
Bess LeRoy, CDISC
REVIEW OF PUBLISHED THERAPEUTIC AREA STANDARDS
John Owen and Jon Neville, CDISC
SESSION 6, TRACK A: DEVELOPMENT & IMPLEMENTATION OF THERAPEUTIC AREA STANDARDS
CONSTRUCT REGISTRY DATABASE OF RARE DISEASES CONSIDERING CDISC STANDARDS
Dr. Satoshi Ueno, National Center of Neurology and Psychiatry
HIV PREVENTION AND TREATMENT PROJECT
Bess LeRoy, CDISC; and Amy Palmer, CDISC
HUNTINGTON’S DISEASE V1.0 PROJECT
Dr. Volker Kern, Critical Path Institute; and Jon Neville, CDISC
CLINICAL TRIAL REGISTRATION (CTR) 2 PROJECT UPDATE
John Owen, CDISC
SESSION 6, TRACK B: INNOVATION
ODM 2.0
Dr. Sam Hume, CDISC
WORK WITH DEFINE-XML - PAST, PRESENT AND FUTURE
Sheng Zhang, FMD K&L
CDISC STANDARDS FACILITATION OF BIG DATA ANALYTICS IN SUPPORT OF RISK-BASED MONITORING
Jon Roth, Biorasi
EHRs: ARE WE THERE YET
Trisha Simpson, UCB
SESSION 6, TRACK C: CDISC FOR NEWCOMERS - 2018 DEVELOPMENTS - SHARE, LABS & LOINC
WHAT IS SHARE, HOW CAN IT BE USED, AND WHAT IS IN THE FUTURE?
Anthony Chow, CDISC
AN OVERVIEW OF LOINC
Dr. Swapna Abhyankar, Regenstrief Institute
MAPPING COMMON RESEARCH LABS TO CDISC AND LOINC
Phil Pochon, Covance
SESSION 7 FIRST CLOSING PLENARY: DATA STANDARDS FOR PATIENT-FOCUSED RESEARCH
PROJECT DATA SPHERE, PATIENT-FOCUSED RESEARCH, DATA STANDARDIZATION AND GOLDILOCKS
Dave Handelsman, Project Data Sphere
IMPACT OF PTSD STANDARD FOR CLINICAL RESEARCH
Dr. Allyson Gage, Cohen Veteran’s Bioscience
INCREASING THE RETURN ON THE RESEARCH INVESTMENT: CLINICAL RESEARCH DATA STANDARDS BEYOND REGULATORY SUBMISSION
Dr. Meredith Zozus, UAMS College of Medicine
BUILDING PEDIATRIC CANCER DATA COMMONS
Dr. Sam Volchenboum, University of Chicago